A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis

作者：Jiang, Guan; Jiang, Ai-Jun; Cheng, Qian; Tian, Hui; Li, Lian-Tao; Zheng, Jun-Nian^*

来源：Tumor Biology, 2013, 34(2): 1263-1271.

DOI：10.1007/s13277-013-0701-7

• Melanoma
• Oncolytic adenoviruses
• Interleukin-24
• Temozolomide
• Apoptosis

Malignant melanoma is one of the most lethal and aggressive human malignancies. Suppressed apoptosis and extraordinary invasiveness are the distinctive features that contribute to malignant melanoma. The alkylating agent temozolomide (TMZ) is one of the most effective single chemotherapeutic agents for patients with malignant melanoma, but resistance develops quickly and with high frequency. We constructed a dual-regulated oncolytic adenovirus expressing interleukin 24 (IL-24) gene (Ki67-ZD55-IL-24) by utilizing the Ki67 promoter to replace the native viral promoter of E1A gene. We investigated whether a combination of Ki67-ZD55-IL-24-mediated gene virotherapy and chemotherapy using TMZ produces increased cytotoxicity against human melanoma cells via the induction of apoptosis. Our data indicate that this novel strategy thus holds promising potentials for further developing an effective approach to treat malignant melanoma.

• 出版日期2013-4
• 单位徐州医科大学